The future of addiction therapy could soon look a lot like treatment for diabetes.
A California-based addiction treatment company hopes to change the way patients struggling with substance abuse disorder receive a popular form of medication-assisted treatment. If approved, patients could self-administer naltrexone, an opioid antagonist, in the comfort of their own homes — like insulin, but for recovering addicts.
Why is the Globe featuring articles on its paid homepage that require an additional paid subscription? Insultingly greedy move. Whoever decided that this was a good idea, is clueless.
Because off danger of precipitating an acute withdrawal reaction giving naltrexone to an active opiate user this should only be done in a medical setting. But hey, california dope fiends get “kicks” from your grand mal seizure if you want.
Comments are closed.